It is a travel and hospitality public limited company based in Aurangabad, Maharashtra, India, established in 2000.
2000 | Aurangabad, Maharashtra, India | ActiveGlobal Transgenes Limited, a active public limited company, was established on 12 January 2000 in Aurangabad, Maharashtra, India. Engaging in consumer professional services within the professional, scientific and technical sector, it holds CIN: U73100MH2000PLC123602. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 9 professional, Its leadership includes Sweta Akash Kagliwal (Director), Jeevanlata Nandkishor Kagliwal (Director), Shrirang Shrikishan Agrawal (Director). Past directors included Akash Nandkishor Kagliwal, Nandkishor Laxminarayan Kagliwal. It holds ₹2.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Nath House Nath Road, Aurangabad, Maharashtra, 431005.
U73100MH2000PLC123602
123602
12 January 2000
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Global Transgenes Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sweta Akash Kagliwal | Director | 25 Mar 2019 | Current |
| Jeevanlata Nandkishor Kagliwal | Director | 25 Mar 2019 | Current |
| Shrirang Shrikishan Agrawal | Director | 31 Dec 2006 | Current |
| Satish Kumar Raina | Director | 31 Dec 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2019 | Past |
| Pramod Abcsdd | Director | 25 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Global Transgenes Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.58% increase in profit. The company's net worth dipped by a decrease of 0.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Global Transgenes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2011 | Department Of Biotechnology | ₹2.65 Cr | Open |
Explore comprehensive loan charge details -
Global Transgenes has a workforce of 9 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Global Transgenes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Transgenes's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Global Transgenes Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Global Transgenes Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Sweta Akash Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was completed.
Jeevanlata Nandkishor Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Progress on A charge with Department Of Biotechnology amounted to Rs. 2.65 Cr with Charge ID 10292996 was registered on 09 Jun 2011. was documented.
Progress on Shrirang Shrikishan Agrawal was appointed as a Director was appointed as a Director on 31 Dec 2006 & has been associated with this company since 18 years 11 months . was documented.
The CIN of Global Transgenes Limited is U73100MH2000PLC123602.
Global Transgenes Limited is headquartered at Nath House Nath Road, Aurangabad, Maharashtra, 431005.
Global Transgenes Limited was incorporated on 12 January 2000.
The current directors of Global Transgenes Limited are
The primary industry of Global Transgenes Limited is Professional, Scientific And Technical.
Global Transgenes Limited is unlisted.
The authorized capital of Global Transgenes Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Global Transgenes Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX